HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS CONFERENCE CALENDAR
LATEST UPDATES » Volume 20, Volume 2, February 2016 Biomedical Research Governance       » Tissue banking in Singapore — An Evolving Enterprise       » China Recognizes Prominent Scientists and Stresses on Innovation       » NUS Researchers Uncover Potent Parasite-killing Mechanism of Nobel Prize-Winning Anti-Malarial Drug       » A New Water Robot "Born" to Detect Water Quality       » Probing the Mystery of How Cancer Cells Die       » Researchers Find Link between Processed Foods and Autoimmune Diseases       » Unravelling the Genetics of Pregnancy and Heart Failure      
BIOBOARD - US
Older mice fed wolfberries show reduced risk for flu virus with vaccine

In a study of older mice, wolfberries appear to interact with the influenza vaccine to offer additional protection against the flu virus. The research, led by scientists at the Jean Mayer USDA Human Nutrition Research Center on Aging (USDA HNRCA) at Tufts University, suggests the wolfberry may increase the activity of dendritic cells, which play an important role in the ability of the immune system to defend against viral infections.

Older mice, with immune systems weakened by age, were placed on diets that included a small amount of a milk preparation of wolfberry fruit, also known as goji berries. Over a period of several weeks, they received two flu vaccines before being infected with the flu virus and monitored for signs of symptoms. The researchers then tested for specific influenza antibodies as well as the clinical symptoms of the disease such as weight loss among the mice.

"We observed higher antibody response and better protection against flu as indicated by less weight loss in the older mice that consumed wolfberries," said senior author Simin Nikbin Meydani, D.V.M., Ph.D., director of the USDA HNRCA at Tufts University and director of the Nutritional Immunology Laboratory at the USDA HNRCA. "While previous studies have shown that wolfberries bolster immune response in mice, our results introduce their potential to reduce the age-related risk and severity of the flu virus in the presence of the vaccine."

Meydani and colleagues isolated dendritic cells, which are known to activate infection-fighting T-cells. The cells were treated with a wolfberry concentrate and incubated for one week. During that time, the researchers observed that the maturity and inflammatory activity of the dendritic cells had increased, which suggests an improved immune response.

"Although we have taken a step toward understanding the mechanism behind the wolfberry's interaction with the flu vaccine, it remains unclear which components of wolfberries may be responsible for the effects observed in this study," said co-corresponding author Dayong Wu, M.D., Ph.D., a senior scientist in the Nutritional Immunology Laboratory and an associate professor at the Friedman School of Nutrition Science and Policy at Tufts University. "Wolfberries are rich in complex carbohydrates known as polysaccharides, as well as vitamins, carotenoids and flavonoids. Future studies in rodent models would be necessary to understand which components appear to be stimulating the dendritic cells."

Further research is also needed to determine whether wolfberries could have a similar effect in older humans who receive the flu vaccine. "People's immune systems inevitably weaken with age, making them less responsive to the vaccine and more susceptible to the flu and its potentially serious complications," said Meydani, who is also a professor at the Friedman School of Nutrition Science and Policy and a member of the immunology program faculty at the Sackler School of Graduate Biomedical Sciences, both at Tufts University. "While flu vaccination is recommended for older people, the vaccine is only 40% effective in protecting older adults against flu infection, which is much lower than that afforded to younger people. For those reasons, it is important to investigate complimentary approaches that may enhance the effectiveness of vaccination."

Click here for the complete issue.

NEWS CRUNCH  
news Singapore Researchers Develop World'S First High-Throughput Imaging Platform for Predicting Kidney Toxicity
news Collaboration is Cure for Better Global Health Outcomes, UK-India Experts Say
news EmTech Asia Opens: Features 50 speakers on innovation and emerging technologies
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  

Primates in Biomedical Research
COLUMNS  
\
APBN Editorial Calendar 2016
January:
Guest Editorial - Biotechnology In Korea
February:
Guest Editorial - Biomedical Research Governance
March:
Guest Editorial - Life-Saving Opportunities: A Guide to Regenerative Medicine
April:
Cancerology / Oncology
May:
Guest Editorial - Antibody Informatics In Japan
June:
Medical Devices and Technology
July:
Water Technology
August:
Occupational Health
September:
Olympics: Evolution of Sports
October:
Respiratory: Seasonal flu viruses
November:
Tobacco Smoking
Editorial calendar is subjected to changes.
– Editor: Carmen, Jia Wen Loh
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» Editorial Enquiries: biotech_edit@wspc.com
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   Ms PoPo Kwok or Ms Sok Ching Lim/td>
Copyright© 2015 World Scientific Publishing Co Pte Ltd  •  Privacy Policy